Original Research
Published on 27 Apr 2026
Determinants of survival in patients treated with CPX-351 for acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1813333
- 469 views
6 articles related to "Cpx 351"
Articles
Mini Review
Published on 17 Nov 2023
CPX-351 in FLT3-mutated acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1271722
- 6,663 views
- 6 citations
Case Report
Published on 16 Sep 2020
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2020.01746
- 3,900 views
- 3 citations
Original Research
Published on 14 Jun 2024
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1347547
- 4,499 views
- 7 citations
Case Report
Published on 25 Jan 2024
CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1291457
- 3,017 views
Mini Review
Published on 19 Jun 2025
Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1609642
- 5,899 views
- 2 citations